| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2022 | Jun 22, 2022 | Qualigen Therapeutics, Inc. | CEO | Buy | 91.3 | +30,000 | 16.65% | ✗ | $17.1K |
| Apr 20, 2021 | Apr 21, 2021 | Qualigen Therapeutics, Inc. | CEO | Buy | 86.3 | +11,005 | 6.50% | ✗ | $19.8K |